期刊文献+

新生儿脐炎病原菌分布与耐药性分析 被引量:25

Pathogenic Bacteria of Newborn Omphlitis:Their Distribution and Resistance
暂未订购
导出
摘要 目的了解新生儿脐炎病原菌和耐药情况,以利于临床选用抗菌药物。方法采用ATB Expression系统鉴定病原菌及药敏试验。结果153份脐分泌物标本,分离出病原菌136株,阳性率88.9%,依次为金黄色葡萄球菌(26.5%)、表皮葡萄球菌(16.2%)、溶血葡萄球菌(13.2%)、肺炎克雷伯菌(13.2%)、大肠埃希菌(9.6%);哌拉西林/他唑巴坦、万古霉素、美罗培南和亚胺培南平均耐药率<2.0%,耐苯唑西林金黄色葡萄球菌(MRSA)占13.9%,耐苯唑西林凝固酶阴性葡萄球菌(MRCNS)占73.2%,超广谱β-内酰胺酶(ESBLs)大肠埃希菌和肺炎克雷伯菌分别为21.4%、44.4%。结论新生儿脐炎的病原菌主要为金黄色葡萄球菌、表皮葡萄球菌、溶血葡萄球菌、肺炎克雷伯菌等,临床医生在用药时需结合药敏结果,加强新生儿护理知识的宣传,有效降低新生儿脐炎。 OBJECTIVE To study the constituent ratio of the pathogentic bacteria of the newborn omphlitis and their resistance. METHODS The bacteria were identified by ATB-Expression system and antibiotic susceptibility tests. RESULTS Of the specimens in 153 cases, there were 136 positive strains (88. 9%). From high to low, Staphylococcus aureus occupied 26. 5%, S. epidermidis occupied 16. 2%, S. haernolyticus occupied 13. 2%, Klebsiella pneurnoniae occupied 13. 2%, and Escherichia coli occupied 9. 6%. Piperacillin/tazobactam, vancomycin, meropenem and imipenem had low drug resistance(2. 0%) that doctors could choose the drugs according to pathogenic bacteria. MRSA occupied 13.9%, MRCNS occupied 73.2%. E. coli and K. penurnoniae of ESBLs accounted for 21. 4% and 44. 4M. CONCLUSIONS The main pathogentic bacteria of the newborn omphlitis are S. aureus, S. epiderrnidis, S. haernolyticus, and K. pneurnoniae. Doctors select the antibiotics according to the results of susceptibility test. It is necessary to advise how attend to the newborn in order to decrease the newborn omphlitis.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2007年第10期1299-1301,共3页 Chinese Journal of Nosocomiology
关键词 病原菌 耐药率 抗菌药物 Pathogentic bacteria Drug resistance Antibiotics
  • 相关文献

参考文献9

二级参考文献25

  • 1周东鹏,李慧娟,张莉,王亚丽.呼吸科病房产超广谱β-内酰胺酶细菌的检测和耐药性研究[J].临床荟萃,2002,17(24):1430-1431. 被引量:3
  • 2刘泽兰 杨幼英.儿科医院感染的前瞻性监控[J].中华医院感染学杂志,1999,9(1):64-64.
  • 3吴瑞萍 胡亚美(等).实用儿科学上册(第6版)[M].北京:人民卫生出版社,1996.445-456.
  • 4王枢群.医院感染监测的发展[J].中华流行病学杂志,1996,17(4):2-2.
  • 5周永书.黄胺嘧啶银乳膏治疗婴幼儿脐炎[J].儿科药学杂志,1998,4(2):43-43.
  • 6National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S].9th informational supplement. Wayne, PA: NCCLS,1999.
  • 7Yagi T, Kurokawa H. A preliminary survey of extended-spectrum L-lactamases (ESBLs)in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan[J]. FEMS Microbiol Lett, 2000,184:54-55.
  • 8Knothe H, Shsh P, Kremery V, etal. Transferable to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens [J].Infection, 1983, 11:315.
  • 9Troche G, Joly LM, Guibert M, et al. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey[J]. Infect Control Hosp Epidemiol, 2005, 26(2): 161- 165.
  • 10Sirot D, Sirot J, Labia R, et al. Transferable resistance to third generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase[J ]. J Antimicrob Chemother, 1987, 20: 323 - 326.

共引文献172

同被引文献156

引证文献25

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部